Health Care [ 11/12 ] | Health Care Providers & Services [ 30/74 ]
NASDAQ | Common Stock
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.
It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 6, 25 | -0.42 Increased by +23.91% | -0.49 Increased by +14.59% |
| Feb 26, 25 | -0.63 Decreased by -18.87% | -0.63 |
| Oct 31, 24 | -0.56 Increased by +16.42% | -0.57 Increased by +1.75% |
| Aug 1, 24 | -0.56 Increased by +9.68% | -0.52 Decreased by -7.69% |
| May 8, 24 | -0.55 Increased by +3.51% | -0.49 Decreased by -12.24% |
| Feb 29, 24 | -0.53 Increased by +27.40% | -0.33 Decreased by -60.61% |
| Nov 2, 23 | -0.67 Decreased by -55.81% | -0.43 Decreased by -55.81% |
| Aug 3, 23 | -0.62 Decreased by -24.00% | -0.69 Increased by +10.14% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -43.33 M Decreased by -32.05% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -38.50 M Decreased by -15.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -38.10 M Decreased by -34.47% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -35.19 M Decreased by -45.35% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 3.68 M Increased by +N/A% | -32.81 M Decreased by -6.11% | Decreased by -891.05% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -33.39 M Decreased by -81.75% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -28.34 M Decreased by -34.69% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -24.21 M Decreased by -14.35% | Decreased by N/A% Decreased by N/A% |